Clinical Trial: Oxytocin Pharmacokinetics and Pharmacodynamics
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Post Partum Hemorrhage
Study Type: INTERVENTIONAL
Official Title: Pharmacokinetics and Pharmacodynamics of Oxytocin in Cesarean Delivery
Brief Summary:
Oxytocin is the first-line drug to promote contraction of the uterus and prevent atony immediately after delivery.Nonetheless, unpredictable uterine atony refractory to oxytocin affects roughly 250,000 parturients annually in the U.S. and rates are increasing.This two-part study will measure the action of oxytocin at cesarean delivery.The first part will measure the pharmacokinetics of a single intravenous (IV) dose of deuterium-labeled oxytocin.The second part will measure the pharmacodynamics of all plasma…
Read more